What's new

Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 47, Status: Authorised

Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 47, Status: Authorised

Apr 3, 2025 - 15:49
 0
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 47, Status: Authorised
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 47, Status: Authorised
Read More

Tags:

Previous Article

Fierce Biotech Fundraising Tracker '25: Neurona nabs $102M; Atsena adds $150M

Next Article

India to double Hanwha self-propelled howitzer buy, will manufacture locally

Related Posts

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 5 December 2024, 09:30 (CET) to 5 December 2024, 13:30 (CET)

Meeting of the Medicine Shortages Single Point of Conta...

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine,tozinameran,riltozinameran and tozinameran,famtozinameran and tozinameran,raxtozinameran, Date of authorisation: 21/12/2020, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025  0

Product Management Service (PMS) – Frequently Asked Que...

Feb 14, 2025  0